Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenqi Buzhong prescription is a Traditional Chinese Medicine (TCM) herbal formula developed by The First Affiliated Hospital of Anhui University of Chinese Medicine. It is part of the Xin'an Guben Peiyuan formula series, which is based on the Xin'an medical tradition of the Anhui province. The prescription is specifically designed for the management of stable chronic obstructive pulmonary disease (COPD), with a focus on "tonifying the middle" (spleen and stomach) to support lung health according to TCM principles. In clinical research, it is evaluated as an adjunctive therapy to standard bronchodilators like tiotropium to assess its efficacy in improving lung function and safety in patients with stable COPD.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenqi Buzhong prescription.